Michael Landsittel
2020
Compensation breakdown
| Non-Equity Incentive Plan | $197,379 |
|---|---|
| Option Awards | $752,845 |
| Salary | $379,575 |
| Stock Awards | $676,625 |
| Other | $8,550 |
| Total | $2,014,974 |
Landsittel received $752.8K in option awards, accounting for 37% of the total pay in 2020.
Landsittel also received $197.4K in non-equity incentive plan, $379.6K in salary, $676.6K in stock awards and $8.6K in other compensation.
Rankings
In 2020, Michael Landsittel's compensation ranked 5,469th out of 13,090 executives tracked by ExecPay. In other words, Landsittel earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,469 out of 13,090 | 58th |
Division Manufacturing | 2,250 out of 5,621 | 60th |
Major group Chemicals And Allied Products | 895 out of 2,254 | 60th |
Industry group Drugs | 772 out of 1,954 | 61st |
Industry Pharmaceutical Preparations | 577 out of 1,459 | 61st |
Pay ratio
| Michael Landsittel's Pay | $2,014,974 |
|---|---|
| Median Employee's Pay | $332,124 |
| Pay Ratio | 6to 1 |
In 2020, the annual total compensation of Michael Landsittel was $2,014,974.
The annual total compensation of the median employee at Blueprint Medicines was $332,124.
The ratio of Michael Landsittel's pay to the pay of median employee was therefore 6 to one.
Landsittel's colleagues
We found four more compensation records of executives who worked with Michael Landsittel at Blueprint Medicines in 2020.